A history of firsts

Pioneering allergy research

Committed to innovation, we develop products which address allergic rhinitis and allergic asthma.

Research-driven treatment

Allergic asthma
Research suggests that allergic rhinitis and allergic asthma are two manifestations of the same condition and could be considered as one disease.
ALK's pipeline
Our tablet portfolio covers the four most significant outdoor allergens in Europe, the USA and Japan (grass, birch and related trees, ragweed and Japanese cedar), and the most important indoor allergen in the world (house dust mites).
Clinical trials
Over recent years, together with our partners, we have invested substantially in the research and development of new, evidence-based SLIT-tablets covering the most important respiratory allergies.
Last updated: 2017.07.03